Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of LY2963016 Versus Lantus in Adults With Type 1 Diabetes Mellitus
jRCT2080221613Phase 3
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of insulin glargine in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Eli Lilly and Company.
02
Drugs
insulin glargine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on jRCT2080221613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221613.